Transforming growth factor-β and receptor tyrosine kinase-activating growth factors negatively regulate collagen genes in smooth muscle of hypertensive rats

Hypertension

Volumn 31, Issue 4, 1998, Pages 986-994

  Bray, Paula ^a   Agrotis, Alex ^a   Bobik, Alex ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Collagen; Genes, c myc; Muscle, smooth, vascular; Rats, inbred SHR; Receptor protein tyrosine kinase; Transforming growth factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN; EPIDERMAL GROWTH FACTOR; PROTEIN TYROSINE KINASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

EID: 0031924269     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.4.986     Document Type: Article

References (48)

1. Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 1982;62:347-504.
2. Mulvany MJ, Hansen PK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media and an increased number of smooth muscle cell layers. Circ Res. 1978;43:854-864.
3. Korner P, Bobik A, Angus JA, Adams MA, Friberg P. Resistance control in hypertension. J Hypertens. 1989;7(suppl 4):S125-S134.
4. Dilley RJ, Kanellakis P, Oddie CJ, Bobik A. Vascular hypertrophy in renal hypertensive spontaneously hypertensive rats. Hypertension. 1994; 24:8-15.
5. Black MJ, Dilley RJ, Bobik A. Renin-dependent hypertension induces smooth muscle polyploidy in large and small vessels. J Hypertens. 1993; 11(suppl 5):S118-S119.
6. Owens GK, Rabinovitch PS, Schwartz SM. Smooth muscle cell hypertrophy versus hyperplasia in hypertension. Proc Natl Acad Sci U S A. 1981;78:7759-7763.
7. Wolinsky H. Response of the rat aortic media to hypertension: morphological and chemical studies. Circ Res. 1970;26:507-522.
8. Cox RH. Basis for the altered arterial wall mechanics in the spontaneously hypertensive rat. Hypertension. 1981;3:485-495.
9. Greenwald SE, Berry CL. Static mechanical properties and chemical composition of the aorta of spontaneously hypertensive rats: a comparison with the effects of induced hypertension. Cardiovasc Res. 1978; 12:364-372.
10. Bashey RI, Cox R, McCann J, Jimenez SA. Changes in collagen biosynthesis, types, and mechanics of aorta in hypertensive rats. J Lab Clin Med. 1989;113:604-611.
11. Ignotz RA, Endo T, Massagué J. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-β. J Biol Chem. 1987;262:6443-6446.
12. Chen J-K, Hoshi H, McKeehan WL. Transforming growth factor type β specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. Proc Natl Acad Sci U S A. 1987;84:5287-5291.
13. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A. 1986;83:4167-4171.
14. Bobik A, Campbell JH. Vascular derived growth factors: cell biology, pathophysiology and pharmacology. Pharmacol Rev. 1993;45:1-42.
15. Sarzani R, Arnaldi G, Takasaki I, Brecher P, Chobanian AV. Effects of hypertension and ageing on platelet-derived growth factor and platelet-derived growth factor-receptor expression in rat aorta and heart. Hypertension. 1991;18(suppl III):III-93-III-99.
16. Agrotis A, Saltis J, Bobik A. Transforming growth factor-β1 gene activation and growth of smooth muscle from hypertensive rats. Hypertension. 1994;23:593-599.
17. Saltis J, Bobik A. Vascular smooth muscle growth in genetic hypertension: evidence for multiple abnormalities in growth regulatory pathways. J Hypertens. 1992;10:635-643.
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
19. Feinberg AP, Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983;132:6-13.
20. Snedecor GW, Cochran WG. Statistical Methods. 7th ed. Ames, Iowa: Iowa State University Press; 1980.
21. Chung K-Y, Agarwal A, Uitto J, Mauviel A. An AP-1 binding sequence is essential for regulation of the human α2(I) collagen (COL1A2) promoter activity by transforming growth factor-β. J Biol Chem. 1996; 271:3272-3278.
22. Liska DJ, Slack JL, Bornstein P. A highly conserved intronic sequence is involved in transcriptional regulation of the alpha I(I) collagen gene. Cell Regul. 1990;1:487-498.
23. Ward MR, Agrotis A, Kanellakis P, Dilley R, Jennings G, Bobik A. Inhibition of protein tyrosine kinase attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury. Arterioscler Thromb Vasc Biol. 1997;17:2461-2470.
24. Throckmorton DC, Brogden AP, Min B, Rasmussen H, Kashgarin M. PDGF and TGF-β mediate collagen production by mesangial cells exposed to advanced glycosylation end products. Kidney Int. 1995;48: 111-117.
25. Kovacs EJ, DiPietro LA. Fibrogenic cytokines and connective tissue production. FASEB J. 1994;8:854-861.
26. Yang B-S, Geddes TJ, Pogulis RJ, de Crombrugghe B, Freytag SO. Transcriptional suppression of cellular gene expression by c-myc. Mol Cell Biol. 1991;11:2291-2295.
27. Yang B-S, Gilbert JD, Freytag SO. Overexpression of myc suppresses CCAAT transcription factor/nuclear factor 1-dependent promoters in vivo. Mol Cell Biol. 1993;13:3093-3102.
28. Alexandrow MG, Kawabata M, Aakre M, Moses HL. Overexpression of the c-myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor β1. Proc Natl Acad Sci U S A. 1995;92:3239-3243.
29. Saltis J, Agrotis A, Bobik A. TGF-β1 potentiates growth factor-stimulated proliferation of vascular smooth muscle cells in genetic hypertension. Am J Physiol. 1992;263:C420-C428.
30. Blackwell TK, Huang J, Ma A, Kretzner L, Alt FW, Eisenman RN, Weintraub H. Binding of myc proteins to canonical and noncanonical DNA sequences. Mol Cell Biol. 1993;13:5216-5224.
31. Amati B, Land H. Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr Opin Genet Dev. 1994;4:102-108.
32. 1 and phorbol myristate acetate on cardiac fibroblasts; regulation of fibrillar collagen mRNAs and expression of early transcription factors. Circ Res. 1991;69:483-490.
33. Liau G, Chan LM. Regulation of extracellular matrix mRNA levels in cultured smooth muscle cells: relationship to cellular quiescence. J Biol Chem. 1989;264:10315-10320.
34. Davidson JM, Zoia O, Liu J-M. Modulation of transforming growth factor-beta 1 stimulated elastin and collagen production and proliferation in porcine vascular smooth muscle cells and skin fibroblasts by basic fibroblast growth factor, transforming growth factor-alpha and insulin-like growth factor-1. J Cell Physiol. 1993;155:149-156.
35. Lawrence R, Hartmann DJ, Sonenshein GE. Transforming growth factor β1 stimulates type V collagen expression in bovine vascular smooth muscle cells. J Biol Chem. 1994;269:9603-9609.
36. Amento EP, Ehsani N, Palmer H, Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb. 1991;11: 1223-1230.
37. Mucsi I, Skorecki KL, Goldberg HJ. Extracellular signal-regulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor-β1 on gene expression. J Biol Chem. 1996; 271:16567-16572.
38. Rossi P, Karsenty G, Roberts AB, Roche NS, Sporn MB, de Crombrugghe B. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta. Cell. 1988;52:405-414.
39. Inagaki Y, Truter S, Ramirez F. Transforming growth factor-β stimulates α2(1) collagen gene expression through a cis-acting element that contains an Sp1- binding site. J Biol Chem. 1994;269:14828-14834.
40. Ritzenthaler JD, Goldstein RH, Fine A, Smith BD. Regulation of the α1(1) collagen promoter via a transforming growth factor-β activation element. J Biol Chem. 1993;268:13625-13631.
41. Jimenez SA, Varga J, Olsen A, Li L, Diaz A, Herhal J, Koch J. Functional analysis of human α1(1) procollagen gene promoter: differential activity in collagen-producing and -nonproducing cells and response to transforming growth factor-β1. J Biol Chem. 1994;269:12684-12691.
42. Ayer DE, Kretzner L, Eisenman RN. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell. 1993;72: 211-222.
43. Marhamati DJ, Sonenshein GE. B-Myb expression in vascular smooth muscle cells occurs in a cell cycle-dependent fashion and down-regulates promoter activity of type I collagen genes. J Biol Chem. 1996;271: 3359-3365.
44. 1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem. 1996;271: 17779-17784.
45. Saltis J, Agrotis A, Bobik A. Differences in growth characteristics of vascular smooth muscle from spontaneously hypertensive and Wistar-Kyoto rats are growth factor dependent. J Hypertens. 1993;11: 629-637.
46. Black MJ, Niklaus A, Bertram JF, Dilley R, Bobik A. Vascular growth responses in SHR and WKY during development of renal (IKIC) hypertension. Am J Hypertens. 1997;10:43-50.
47. Botney MD, Bahadori L, Gold LI. Vascular remodelling in primary pulmonary hypertension: potential role for transforming growth factor-β. Am J Pathol. 1994;144:286-295.
48. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS. Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A. 1995;92:2572-2576.